Cumberland Pharmaceuticals Inc. Long-term Line of Credit, Noncurrent
Cumberland Pharmaceuticals Inc. (CPIX) had Long-term Line of Credit, Noncurrent of $0 as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermLineOfCredit · last filed 2026-08-07
- 2026-06-30: Long-term Line of Credit, Noncurrent $0.00.
- 2026-03-31: Long-term Line of Credit, Noncurrent $5.24M.
- 2025-12-31: Long-term Line of Credit, Noncurrent $5.24M.
- 2025-09-30: Long-term Line of Credit, Noncurrent $5.24M.
| Period end | Long-term Line of Credit, Noncurrent | Long-term Line of Credit, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $5.24M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $5.24M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $5.24M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $5.24M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $5.24M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $10.18M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $10.10M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $16.09M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $16.08M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $12.78M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $12.92M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $13.15M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $16.07M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $16.20M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $17.70M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $19.00M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $20.00M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $15.00M 10-K · filed 2023-03-13 | |
| 2021-09-30 | $15.00M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $14.00M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $15.00M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $15.00M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $15.00M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $17.00M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $18.50M 10-Q · filed 2020-05-22 | |
| 2019-12-31 | $18.50M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $20.00M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $20.00M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $20.00M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $20.00M 8-K · filed 2020-12-10 | |
| 2018-09-30 | $12.00M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $12.00M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $12.00M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $9.80M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $8.00M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $6.70M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $4.10M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $4.10M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $3.70M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $3.50M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $1.70M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $1.70M 10-K · filed 2017-03-13 | |
| 2015-09-30 | $1.70M 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $1.70M 10-Q · filed 2016-08-05 | |
| 2015-03-31 | $1.70M 10-Q · filed 2016-05-13 | $0.00 10-Q · filed 2015-05-15 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-14 | |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-09 | |
| 2013-09-30 | $4.86M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $5.86M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $4.36M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $4.36M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $4.36M 10-Q · filed 2012-11-02 | |
| 2012-06-30 | $4.36M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $5.11M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $4.86M 10-K · filed 2013-03-12 | |
| 2011-09-30 | $4.58M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $1.83M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $1.83M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |